Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
Completed
Sanofi
Phase 1
2009-09-01
This study is aimed at assessing the tolerability and pharmacokinetic parameters of the
fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental
Trypanosomiasis infections, fexinidazole shows highly promising efficacy.
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
Completed
Drugs for Neglected Diseases
Phase 1
2009-09-01
This study is aimed at assessing the tolerability and pharmacokinetic parameters of the
fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental
Trypanosomiasis infections, fexinidazole shows highly promising efficacy.
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
Completed
Sanofi
Phase 1
2011-02-01
The present study is designed to assess the impact of concomitant food intake on the relative
bioavailability of a single oral fexinidazole tablet administration.
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
Completed
Drugs for Neglected Diseases
Phase 1
2011-02-01
The present study is designed to assess the impact of concomitant food intake on the relative
bioavailability of a single oral fexinidazole tablet administration.
Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food
Terminated
Drugs for Neglected Diseases
Phase 1
2011-09-01
This trial will study the tolerability and pharmacokinetic of fexinidazole using two
different dosage regimen of repeated administrations. The drug is administered to human
healthy volunteers of sub-saharan origin together with food, once a day during 10 days, with
a loading dose during 4 days.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
